Please login to the form below

Not currently logged in
Email:
Password:

GIST

This page shows the latest GIST news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca launches $1bn Chinese investment fund

AstraZeneca launches $1bn Chinese investment fund

AZ has bolstered its oncology pipeline with a KIT inhibitor for gastrointestinal stromal tumours (GIST) from Ningbo Tai King Medical Technology – now called AZD3229 – and an ERK 1/2 inhibitor for

Latest news

More from news
Approximately 2 fully matching, plus 44 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

Infographics